trending Market Intelligence /marketintelligence/en/news-insights/trending/oW-BDkM7oNA2kSQXdkbHCw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Aradigm regains compliance with Nasdaq listing rule

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Aradigm regains compliance with Nasdaq listing rule

Aradigm Corp. regained compliance with the Nasdaq listing rule requiring the company to maintain a market value of listed securities of $35 million or greater for 10 consecutive business days.

The specialty pharmaceutical company received a noncompliance notice from Nasdaq on April 4, saying the company did not comply with the minimum requirement of $2.5 million stockholders' equity, or $35 million market value of listed securities, or $500,000 of net income from continuing operations.

Aradigm will continue to be listed on the Nasdaq Capital Market.